The U.S. Food and Drug Administration has accepted two Abbreviated New Drug Applications (ANDAs) from Sandoz for proposed generic tirzepatide autoinjectors. Developed entirely in-house, the…
July 15, 2026
Gated Content
Sign up to get access
"*" indicates required fields
Sign up to get access
Please provide accurate and verifiable contact information to ensure proper use of our materials and prevent misuse. Thank you for your understanding!